SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...

EST Maravai Lifesciences (MRVI) jumps 6% to $5.85 after MAI IP acquisition announcementInvest with Confidence: Follow TipRanks' Top Wall ...

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

Please find enclosed outcome of the Board Meeting dated October 25, 2024 ...

Zai Lab Limited today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly active first-in-class DLL3 antibody-drug conjugate ...

Thank you for taking the time to look more closely into the offerings of the University of Vermont’s Cellular, Molecular, and Biomedical Sciences (CMB) doctoral program. The CMB program has at its ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

WASHINGTON, Jan. 16, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration's (FDA) proposed rule to make cigarettes and certain other combusted tobacco products minimally or nonaddictive by ...

Prices shown are in the currency of the stock selected. For example, if a UK stock is chosen these figures are in sterling, if a US stock chosen then the figures shown are in dollars. Important ...